Establishment of reference values of markers of non-thyroidal illness syndrome on a state-of-the-art fully automated ABEI-based chemiluminescence system

Read full text
Authors: Aamir Ijaz, Muhammad Usman Anjum, Farhan Ahmed, Shamila Najeeb Paracha, Farzana Habib, Muhammad Bilal Shaukat, Sara Najeeb, Najma Hafeez
Cited by: 0
References: 31

Abstract

Abstract Background Non-Thyroidal Illness Syndrome (NTIS), previously called Euthyroid Sick Syndrome has always been a diagnostic dilemma for Chemical Pathologists and treating physicians. Combination of four test i.e. Reverse Triiodothyronine (rT3), Free Triiodothyronine (fT3), Free Thyroxine (fT4) and Thyroid Stimulating Hormone (TSH) can be helpful to diagnose NTIS in critically ill patients. We need, however, to determine the reference values found in a reference population, free of any thyroidal as well as non-thyroidal illness. Methods and Materials Initially, 266 adult volunteers were included in the study from Mohi Uddin Islamic Medical College Mirpur AJ&K (MIMC) and Mohi Uddin Teaching Hospital Mirpur AJ&K (MOTH) after taking written informed consent. About 124 volunteers were selected (males 61; females 63) after exclusion of the volunteers with one or more of the exclusion criteria. Blood specimens were collected and analyzed for rT3, fT3, fT4 and TSH using Maglumi X8 (S nibe, China), an ABEI (N-(aminobutil)-N-(ethyl)-isoluminol) based analyzer at Pathology Laboratory MOTH. Results Reference values of rT3, fT3, fT4 and TSH were found to be 13.3 – 19.8 ng/dL (0.2 – 0.30 nmol/L); 2.65 - 4.15 pg/mL (4.08 - 6.39 pmol/L);10.6 - 16.2 pg/mL (13.64–20.84 pmol/L) and 0.43 - 3.98 μIU/mL (0.43 – 3.98 mIU/L), respectively. Conclusion Reference values determined in our own population should be used when diagnosing and monitoring NTIS and other thyroid disorders

Fields of Study & Subjects

bioluminescence and chemiluminescence research Advanced Chemical Sensor Technologies

Publication details

Journal / source
Pakistan Journal of Pathology
Volume
37
Issue
2
Pages
81–88
Publication date
30 June 2026
Language
EN